영천바이오에너지

비상장계속사업자

Yeongchen Bio Energy Co.,LTD.

장호철

Investment Review Report

Auto-filled from disclosures & public data + AI-drafted analysis. Edit, then export to PDF/DOCX.

Editor

1.Deal Terms

2.Valuation / Exit Assumptions

Exit Scenarios100M KRW

3.Fund Eligibility

Fund mandate eligibility — no data, enter manually

Enter fund mandate requirements and applicability (Y/N) to include a table in the report.

4.Capital Changes

Not in DART — enter capital-raise history manually

Enter capital changes such as founding capital and paid-in increases.

5.Stock Options

Enter manually

Enter stock option grant history.

6.Investment Highlights

AI draft — editable

Click 'Generate AI draft' to populate data-grounded investment highlights.

7.Investment Risks

AI draft — editable

Risks are populated after 'Generate AI draft'.

8.Market Analysis

AI draft — editable

9.Business Analysis

AI draft — editable

10.Conclusion (Investment Opinion)

AI draft — editable

11.P&L Projection

Analyst estimates, manual entry (100M KRW). Generates a trend chart & table.

Enter projected revenue / op. profit / net income (100M KRW) by year to add a trend chart and table.
Preview— the document below is saved as PDF/DOCX

Investment Review Report

영천바이오에너지

Business Reg. No. 5058182199 · CEO 장호철

I.Investment Overview

Target영천바이오에너지 (5058182199)
Investment
Post-deal stake
ValuationPre — / Post —

II.Investment Highlights

No investment highlights written yet.

III.Investment Risks

No risks written yet.

IV.Company Profile

회사명영천바이오에너지
영문명Yeongchen Bio Energy Co.,LTD.
대표자장호철
사업자등록번호5058182199
법인등록번호1747110038013
설립일2014.10.21

V.Financial Summary

Per DART disclosure · in 억/만원 (KRW)

Financial trend (100M KRW)

매출액100M KRW49.8202153202244.9202343.7202444.72025
영업이익100M KRW10.7202111.520227.520235.7202472025
순이익100M KRW3.120214202212023-0.420242.52025
Item20252024202320222021
자산총계116.7억원120.1억원138.7억원135.6억원134.6억원
부채총계82.8억원88.7억원106.8억원104.8억원107.7억원
자본총계33.9억원31.4억원31.9억원30.9억원26.9억원
매출액44.7억원43.7억원44.9억원53억원49.8억원
영업이익7억원5.7억원7.5억원11.5억원10.7억원
순이익2.5억원-4,354만원9,799만원4억원3.1억원

VI.Financial Ratios

FY2025 basis

15.68%

영업이익률

5.61%

순이익률

2.15%

ROA

7.39%

ROE

244.01%

부채비율

29.07%

자기자본비율

VII.Valuation & Exit Plan

Exit valuation
Holding period5y
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.

This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.

영천바이오에너지 투심보고서 | Alpha Lenz